Translation and Validation of EORTC QLQ-C30 into Indonesian Version for Cancer Patients in Indonesia
Open Access
- 25 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 41 (4) , 519-529
Abstract
Quality of life studies in Indonesia are still uncommon. This research was aimed to validate the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 in Indonesian version. The standard procedure of forward–backward translation was adhered to in the translation procedures. The validity procedure included reliability, convergent and discriminant validity, known-groups validity, factor analysis and external convergent validity. Data were collected from cancer patients in the Oncology Department of Sardjito Hospital, Yogyakarta, Indonesia, who were treated with cisplatin at the dosage ≥50 mg/m2 as monotherapy or in combinations. The Short Form-36 was used to assess the external convergent validity of our translated questionnaire. One hundred and twenty-eight patients were recruited from March 2009 to November 2009. The internal consistency with values of >0.70 was observed in the Indonesian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 scales. All items in the questionnaire met the criteria of convergent and discriminant validity, except for items 5. Both of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and the Short Form-36 showed that different diagnoses were associated with a similar impact on quality of life. Factor analysis showed that only the role function and social function loaded onto the second factor together. Correlations between the Indonesian versions of both questionnaires were moderate: between 0.18 and 0.48 for the physical, emotional, social, fatigue and pain domains. The Indonesian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 can be used as a questionnaire to assess quality of life in Indonesian cancer patients with high-emetogenic treatments.Keywords
This publication has 18 references indexed in Scilit:
- Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic‐speaking PopulationsAnnals of the New York Academy of Sciences, 2008
- Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancerAnnals of Oncology, 2008
- Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemiaHealth and Quality of Life Outcomes, 2008
- Validation and Comparison of the Health-Related Quality-of-Life Instruments EORTC QLQ-C30 and SF-36 in Assessment of Patients with Chronic Nonmalignant PainJournal of Pain and Symptom Management, 2007
- Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approachEuropean Journal of Cancer, 2007
- Conceptual equivalence and health-related quality of life: an exploratory study in Japanese and Dutch cancer patientsQuality of Life Research, 2006
- The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation of English version in SingaporeQuality of Life Research, 2005
- Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During ChemotherapyHealth and Quality of Life Outcomes, 2003
- Translation and validation of the Standard Chinese version of the EORTC QLQ-C30Quality of Life Research, 2000
- Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) ProjectJournal of Clinical Epidemiology, 1998